Human cord blood was used as a source of progenitor and stem cells t o evaluate the effect of recombinant human stem-cell factor (SCF) on colony formation and the generation of colony-forming cells (CFC) under highly defined, serum-deprived conditions. SCF interacted with a number of hematopoietic growth factors t o stimulate colony growth and was particularly effective in stimulating the formation of mixed-cell colonies from CD34+ soybean agglutinin negative (SBA-) cells. In suspension culture of CD34+, SBA-cells, SCF alone was unable t o maintain cell numbers or CFC but, in combination with interleukin-3 (IL-3). increased input numbers of cells by IO-fold and increased CFC of all kinds by nearly 20-fold. This included erythroid burst-forming cells (BFU-E), granulocyts/macrophage (GM) CFC, and mixed-cell CFC. In contrast, CD34-SBA-cells neither gave rise t o CFC nor were maintained by combinations of growth factors including SCF. SCF interacted with erythropoietin (Epo) and TEM CELL FACTOR (SCF) is a newly identified s growth that may participate in the development of a number of organs and tissues6 In the mouse, SCF is the product of the steel locus and the ligand for the c-kit gene product. Animals with inherited mutations at either locus7-9 express a variety of constitutional changes, including macrocytic anemia, defective primordial germ cells, altered coat color, and reduced or absent mast cells. SCF is expresed differentially by a variety of tissues during murine embryogenesis6 and, thus, may participate in the development of multiple organ systems.
Studies with murine SCF have shown its capacity to interact with a variety of hematopoietic growth factors to promote the growth of different kinds of colony-forming cells (CFC) and, most particularly, mixed-cell CFC.lopll In addition, we have recently shown12 that highly enriched populations of murine hematopoietic cells, having little colony-forming ability themselves, can give rise over time to large numbers of CFC as well as differentiated cells in the o I992 by The American Society of Hematology.
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granulocyte colony-stimulating factor (G-CSF) t o maintain large numbers of cells as well as t o generate a twofold to threefold increase in CFC in the case of Epo, and a 10-fold increase in CFC in the case of G-CSF. With Epo, the predominant CFC generated were BFU-E and erythroid CFC and many of the cells in suspension were erythroblasts. In contrast, SCF plus G-CSF resulted in large numbers of granulocytes at various stages of maturation and the CFC generated were almost exclusively granulocytic-CFC. IL-I and IL-6, alone or in combination with SCF, showed little or no ability t o increase cell numbers or generate CFC. In summary, SCF interacts with a variety of hematopoietic growth factors to promote colony formation, particularly mixed-cell colony formation, and also, in suspension culture, SCF interacts with IL-3, G-CSF, and Epo t o generate large numbers of differentiated cells as well as a variety of CFC for up t o 1 month. 0 1992 by The American Society of Hematology.
presence of rattine SCF in combination with other growth factors, such as interleukin-3 (IL-3). Thus, SCF acts at an earlier level than other known growth factors and may have the capacity to affect the earliest hematopoietic stem cells-those responsible for long-term marrow reconstitution.
The gene for human SCF has recently been isolated and expressed.' Early studies13J4 with recombinant human SCF have confirmed its ability to interact with other growth factors to enhance not only colony numbers but also the size of colonies. Thus, in the presence of SCF, macroscopic colonies are formed in semisolid medium.
In studies analogous to those that we performed with murine cells,12 we used recombinant human SCF to examine its ability to interact with a number of other hematopoietic growth factors to promote colony formation by CFC from cord blood. We have also isolated CD34+ soybean agglutinin negative (SBA-) cord blood cells and studied the effect of SCF and its ability to generate CFC. We have operationally defined the source of the CFC generated as pre-CFC. Based on our own studies12 and the studies of others,I5 pre-CFC must account for at least part of the source of CFC generated by SCF, if not all.
Our results indicate that SCF, in combination with other growth factors, can sustain and increase the total number of nucleated cells in suspension culture for up to 1 month and can generate large numbers of CFC from pre-CFC in these cultures. Thus, human SCF is the earliest acting growth factor studied to date and may have the ability to directly affect pluripotent hematopoietic stem cells, those cells capable of long-term marrow reconstitution. . The nonadherent cells (defined for our purpose as CD34-) were removed with a pipette, and the adherent cells (CD34+) were recovered by washing the flask with fresh medium after mechanical shaking. Interestingly, the majority (75% to 80%) of the CD34+ cells were erythroblasts. The standard colony-forming efficiency of CD34+ cells enriched by this technique ranged from 0.5% to 2%.
The purified recombinant human hematopoietic growth factors used included erythropoietin (Epo),18 granulocyte colony-stimulating factor (G-CSF),19 SCF,' granulocyte/macrophage (GM)-CSF?O and IL-3J1 GM-CSF, G-CSF, IL-3, and SCF were used at concentrations that induced the optimal response in fetal bovine serum (FBS)-deprived cultures of human marrow cell^.^^,'^ These concentrations are 4.5 x mol/L of GM-CSF, 2 x mol/L of IL-3, 10 ng IL-l/mL,22 30 ng IL-6/mL,= 100 ng SCF/mL and 1.5 U Epo/mL per culture. Epo was used at a concentration (1.5 U/mL) found to be optimal in promoting erythroid burst growth in FBS-supplemented cultures.16 CD34+ (lo4 cells/well) or CD34-(5 x 104 cellsiwell) cord blood cells were incubated in liquid culture for up to 27 days. The culture medium was composed of IMDM supplemented with P-mercaptoethanol (7.5 x mol/L), antibiotics (100 U of penicillin, 250 ng of amphotericin B, and 100 p,g of streptomycin), and a mixture of nutrients designed to replace FBS, composed of deionized bovine serum albumin (BSA; 2 x mol/L), BSA-adsorbed cholesterol (4 kg/mL) and soybean lecithin (12 pg/mL), iron-saturated human transferrin (5 x lo-' mol/L), insulin (1.7 x mol/L), nucleosides (10 p,g/mL each), inorganic salts, sodium pyruvate mol/L), and L-glutamine (2 X mol/L) as des~ribed.2~9~~ All the chemicals were obtained from Sigma Chemical (St Louis, MO). The number of CFC in the culture was evaluated at different intervals by culturing an aliquot (20%) of the suspension volume in FBS-supplemented semisolid medium as described below. The cultures were stimulated with a combination of growth factors previously shown to induce maximal colony formation. The growth factors, alone or in combination, were added once, at the outset of the culture.
Hematopoietic growth factors.

mol/L of G-CSF, 2 x
Liquid culture.
Colony assay. Each 1 mL dish contained components identical to those in the liquid culture except that FBS (Hyclone, Logan, UT; 30% vol/vol) and BSA (0.9%) replaced the FBS-replacing nutrients, and methylcellulose (0.8% wt/vol, final concentration) was added. Various combinations of growth factors were added to the dish at appropriate concentrations to stimulate colony growth. These included Epo, IL-3, and SCF for BFU-E and mixed-cell CFC growth; and G-CSF, IL-3, and SCF for GM-CFC growth.
All cultures were established in duplicate. Plates were incubated at 37°C in a fully humidified incubator with 5% COz in air and scored at 12 to 14 days for the presence of elythroid bursts, GM colonies, and mixed-cell colonies. Erythroid bursts (containing > 200 cells) were identified on the basis of their orange-red color. Colonies composed of more than 50 nonerythroid cells were scored as GM colonies. Colonies containing more than 5 x lo3 cells composed of both erythroid and nonerythroid elements were scored as mixed-cell colonies.
Scoring criteria.
RESULTS
The effect of SCF, alone and in combination with other growth factors, on colony formation by cord blood cells. Figure 1 shows the effect of SCF, alone and in combination with a variety of growth factors, on colony formation by SBA-, CD34+ progenitor cells. SCF had little colonystimulating activity alone but interacted with all other growth factors tested to enhance GM colony formation and, in particular, mixed-cell colony formation. Only erythroid burst growth was not enhanced by the presence of SCF and this was accounted for by a marked increase in mixed-cell colonies under these conditions. Thus, as we have seen previ~usly,'~ the addition of SCF to cultures alters the identity of erythroid bursts to mixed-cell colonies. The number of mixed-cell colonies under serum-deprived conditions increased by a factor of 5 to 10 over the number of mixed-cell colonies seen with the combination of Epo, G-CSF, GM-CSF, and IL-3.
The effect of SCF, alone and in combination with other growth factors, in liquid suspension culture of cord blood cells. Figure 2A shows the effect of SCF and IL-3 on total cell numbers in liquid suspension culture of CD34-or CD34+ cells. In the absence of growth factor, viable cells were gone by 10 to 15 days. In the presence of SCF and IL-3, CD34-cells were nearly maintained over a 3-week period while the original CD34+ cell population increased in numbers by greater than 10-fold. Figure 2B , C, and D charts the changes in numbers of various CFC in the presence of SCF and IL-3. Compared with the CD34+ population, there were relatively few erythroid burst-forming cells (BFU-E), GM-CFC, or mixedcell CFC in the input CD34-cells, and there were no increases in any types of CFC from CD34-cells in the presence of SCF and IL-3.
In contrast, up to 2% of the CD34+ cells at input were CFC of one type or another. In the presence of SCF and IL-3, the number of BFU-E increased fivefold over input numbers by day 10 and then subsequently declined. GM-CFC also increased in number and continued to be generated throughout 3 weeks of culture. Mixed-cell CFC had increased threefold over input numbers by the end of the culture period. At day 10 of culture, the total number of CFC had increased nearly fivefold over the input value and now comprised 5% of the total cell number.
Figures 3 and 4 provide more detailed information on the effects of IL-3 and SCF, alone and in combination, on For changes in cell number and CFC number in cultures of CD34+ cells. SCF alone nearly maintained total cell numbers and gave rise to a slight increase in CFC of all types, especially BFU-E and mixed-cell CFC. IL-3 alone maintained total cell numbers for up to 20 days (but not beyond) and gave a slight increase in the number of BFU-E. These results are similar to those already SCF affected GM-CFC and mixed-cell CFC little or not at all. The combination of IL-3 and SCF gave rise not only to increased numbers of cells but also an increased number of CFC of all types with a pattern similar to that seen in Fig 2. In subsequent experiments, SCF was tested in combination with other growth factors reported to be able to affect primitive progenitor cells. In Fig 5, the effect of IL-1, alone or in combination with SCF, is shown. By itself, IL-1 was unable to maintain total cell numbers or CFC over and above cultures to which no growth factors had been added. The combination of IL-1 and SCF maintained cell numbers somewhat better than SCF alone but no increase in total cell numbers above the input value was observed. Alone, IL-1 was incapable of maintaining CFC numbers over cultures to which no growth factor was added and failed to increase CFC numbers over and above those maintained with SCF alone. Figure 6 shows the interaction of SCF and IL-6. IL-6 alone was unable to maintain cell numbers or CFC over and above cultures to which no growth factors had been added. However, the combination of IL-6 and SCF increased total cell numbers late in culture (peak at 20 days) above input values, and the combination was more active than the cultures containing SCF alone. The presence of IL-6 increased total CFC numbers slightly above cultures containing SCF alone. Figure 7 shows the effects of Epo alone and in combination with SCF. Epo alone maintained cells for up to 2 weeks and was more active than SCF alone. Epo plus SCF combined to increase total cell numbers to the same extent that SCF plus IL-3 did. There was also a marked difference in the morphology of the cells generated over 2 to 3 weeks with approximately one-third being erythroblasts of various stages of maturation.
Epo alone had little ability to maintain CFC; however, the combination of Epo plus SCF was better than SCF alone in generating CFC. The majority of CFC generated were BFU-E and erythroid colony-forming cells (CFU-E).
The effect of G-CSF, alone and in combination with SCF, is shown in Fig 8. In the presence of SCF alone, total cell numbers declined by 75% by day 5 of culture but then rebounded to input values between weeks 2 and 3. The combination of G-CSF and SCF was more active than SCF plus IL-3 in increasing cell numbers and, once again, the morphology of the cells generated was different under the two conditions. In the presence of G-CSF and SCF, neutrophils predominated ( > 85%), whereas with IL-3 and SCF, multiple lineages were represented (data not shown). Alone, G-CSF had little effect on CFC numbers. However, the combination of G-CSF plus SCF was as effective as IL-3 plus SCF in generating CFC. Under these conditions, the predominant CFC generated gave rise to large granulocytic colonies.
DISCUSSION
SCF is emerging as a potent hematopoietic growth factor, particularly able to interact with a variety of other growth factors to influence very early progenitor cells. Although SCF, by itself, showed little colony-stimulating activity, we have shown in previous studied2 that SCF is required for the generation of substantial numbers of CFC from pre-CFC in suspension culture of murine progenitor cells enriched on the basis of their ability to bind the mitochondrial dye, Rhodamine 123. Furthermore, the addition of recombinant SCF to culture of purified marrow progenitor cells containing Epo and IL-3 yielded a cloning efficiency for mixed-cell CFC higher than any previously reported.14 Consistent with the reports of others,11J3 and our own data,12J4 recombinant SCF had little colony-stimulating activity by itself when cultured with various progenitor cell populations, including partially purified human marrow cells, peripheral blood cells, or cord blood cells, under serum-deprived conditions. However, SCF interacted with other growth factors to give rise to macroscopic colonies and was particularly effective in promoting the growth of mixed-cell colonies to values 5 to 10 times greater than values previously reported for unfractionated cord blood cells.
In the parallel studies reported here, we have used physical separation of cord blood mononuclear cells to isolate target cells enriched for CD34 antigen expression and lacking T cells, B cells, and monocytes. The effectiveness of the cell separation technique was evident in the colony-forming ability of the populations isolated on the basis of the expression of CD34+. CD34-cells had relatively few CFC compared with CD34+ cells. In liquid culture, CD34-cells could be maintained in terms of total cell numbers for up to 3 weeks in the presence of SCF and IL-3, but lacked the capacity under these conditions to give rise to CFC from pre-CFC.
In contrast, freshly isolated CD34+ cells had up to 2% primary cloning efficiency under FBS-deprived conditions, contained CFC of all types tested, and were able to give rise to differentiated cells as well as to large numbers of CFC from pre-CFC. Under these conditions, the combination of SCF and IL-3 was the most active in generating CFC. 
org From
However, as shown in Figs 7 and 8, other hematopoietic growth factors, including Epo and G-CSF, were capable of increasing the effectiveness of SCF in generating CFC and gave rise to large numbers of differentiated cells. In the presence of Epo and SCF, the predominant CFC generated were BFU-E and, from them, CFU-E. In the presence of SCF and G-CSF, the predominant CFC generated gave rise to large granulocytic colonies. The effect of these growth factors was also seen in the types of cells that accumulated over time, being substantially erythroid in the presence of Epo and almost exclusively neutrophils in the presence of G-CSF. G-CSF and Epo are considered by many to be factors that act on progenitors capable only of terminal and lineage-restricted maturation. However, in earlier studies of murine marrow cells in suspension culture, we showed that Epo had the ability, under highly defined, serumdeprived conditions, to generate increased numbers of BFU-E, presumably from even more primitive cells. In the experiments presented here, SCF plus Epo gave rise to very large numbers of erythroid CFC of various kinds while SCF plus G-CSF drove the cultures toward granulopoiesis. It remains to be determined whether SCF acts on cells that can then respond either to Epo or G-CSF, or whether SCF expands or primes cells of multiple lineages, part of which are then allowed to divide and mature depending on the second growth factor added. Experiments to address this question are underway.
Studies with IL-6 and IL-1, growth factors believed to act very early in hematopoiesi~,2~,~~ failed to show significant interaction with SCF. Under the conditions tested, IL-1 and IL-6 were essentially inactive, by themselves, in either maintaining cells or generating CFC from pre-CFC.
These results, on enriched populations of cord blood In these studies, CD34+, lin-cells gave rise to CFC of various kinds with a time course and degree of amplification similar to the data presented here. Of interest, IL-6 appeared to be active under culture conditions including FBS, whereas in our hands it was not. Although the differences may be attributed to adult versus neonatal target cells, we have previously shown that IL-6, under highly defined conditions, has little or no colony-stimulating activity alone or in combination with other growth factors in cultures of adult human marrow cells.29
Other studies also have led to the conclusion that SCF acts earlier in hematopoiesis than other known growth factors and also is capable of inducing some degree of self-renewal. Carow et aI3O reported that SCF supported the growth of large numbers of adult marrow and cord blood mixed-cell CFC, and allowed an increased efficiency of replating from mixed-cell CFC. Dai et aP1 have reported that SCF was required for the early cell divisions and progress of human BFU-E and Andrews et a132 have reported that human SCF, infused into baboons, increased the number of CFC. These results were similar to those of Molineux et aP3 who showed the ability of SCF to expand marrow repopulating cells in vivo in the mouse.
Cord blood differs from adult marrow in several ways, including having a greater frequency (350 versus 290/ lo5 SBA-cells) of mixed-cell CFC.14 Furthermore, the colonies that arise in cultures of cord blood are, for the most part, much larger than colonies arising in adult marrow cell For personal use only. on October 23, 2017. by guest www.bloodjournal.org From cultures, suggesting a greater proliferative potential for cord blood progenitors.
Another difference between adult human marrow and cord blood cells is the loss of CFC with the various enrichment techniques. As originally reported by Broxmeyer et al,34 simple density gradient separation of cord blood cells results in about a 50% loss of CFC. As shown in Table 1 , this has been our experience as well, and contrasts with the full retention (and even enhancement) of CFC seen with the typical separation of adult marrow. 15 Cord blood was used for these studies for several reasons. First, it is a highly rich source of progenitor cells of all kinds, including cells capable of marrow engraftment. Cord blood stem cells have been used successfully for allografting on at least four occasion^.^^^^^ Second, as a rich source of stem cells, cord blood is a useful tissue with which to explore the possibility that SCF, alone or in combination with other growth factors, might be able to amplify those cells capable of engraftment. This could prove useful in the expansion of stem cell numbers posttransplantation or, possibly, SCF in combination with other growth factors could amplify stem cell numbers invitro before engraftment. It should be noted that the degree of expansion of cell numbers and CFC reported here is likely to be a minimum estimate given the fact that the medium and growth factors were not replenished over the 3-to 4-week culture period.
Because SCF acts on earlier cells than any of the other growth factors studied, it will be important to determine if the loss of pre-CFC parallels the loss of CFC in the physical separation of cord blood cells. This is now possible to address experimentally using highly selected CD34+, lincells and by removing the contaminating erythroblasts that, in cord blood, apparently express high levels of CD34.
Finally, as we and others have suggested, the use of SCF to move cells that are not in cell cycle into the cycling state may open possibilities for retroviral gene transfer and therapeutic strategies for a variety of inherited human diseases.
